Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
02/24/2005 | US20050044580 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
02/24/2005 | US20050043527 Delta-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts |
02/24/2005 | US20050043526 Sigma factor A (SIGA) protein for use as tool in expression of operons associated with lysine biosynthesis; ennhancing animal feeds; cosmetics; medicine |
02/24/2005 | US20050043525 Nucleotide sequences coding amidotransferase for use in identifying modulator for use in identifying microbiocides, fungicides and/or herbicidal agents |
02/24/2005 | US20050043520 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
02/24/2005 | US20050043297 Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical |
02/24/2005 | US20050043265 High affinity RNA ligands of basic fibroblast growth factor |
02/24/2005 | US20050043259 Using transfer rna splicing endonuclease and oligonucleotide probes to preferentially locate, hybridize and split target messenger rna sequences comprising bulge-helix-bulge conformations |
02/24/2005 | US20050043256 antisense oligonucleotides, are targeted to a nucleic acid encoding stearoyl-CoA desaturase, and modulate the expression of stearoyl-CoA desaturase; gene therapy; genetic engineering; for treatment of abnormal lipid metabolism, obesity |
02/24/2005 | US20050043241 Use of inhibitors of given amino acid sequence; inhibit phosphorylation of a transcription factor; can be used to treat or prevent diabetes, ionizing radiation damage, autoimmune diseases, ischemia/reperfusion injuries, heart hypertrophies, cancer |
02/24/2005 | US20050043232 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
02/24/2005 | US20050043198 A related nucleic acid, expression vector, host cell, and protein, the protein having a common epitope with the protease; the protease acts as an unspecific endopeptidase; cleaners also contain an amylase, cellulase, hemicellulase, oxidoreductase, or lipase; cosmetics |
02/24/2005 | US20050042739 Enzymatic polypeptide for use as tool in identifying modulator for treatment and prevention of immunological and viral diseases |
02/24/2005 | US20050042737 Starch process |
02/24/2005 | US20050042735 Metabolic engineering for enhanced production of chitin and chitosan in microorganisms |
02/24/2005 | US20050042734 incubation of starches, maltodextrins or glycogen with an ammonium source in a reaction mixture contaiinig cell extracts comprising glucosamine-6-phosphate deaminase activity, to form glucosamine-6-phosphate |
02/24/2005 | US20050042730 Gene screening method using nuclear receptor |
02/24/2005 | US20050042727 UDP-N-acetylglucosamine: galactose-Beta 1,3-N-A-acetylgalactosamine-alpha-R/N-acetylglucosamine-Beta 1,3-N-acetylgalactosamine-alpha-R (GIcNAc to GalNac) Beta 1,6-N-acetylglucosaminyltransferase, C2/4GnT |
02/24/2005 | US20050042722 Isolated nucleic acid encoding enzyme; chimera gene expression; genetic engineering |
02/24/2005 | US20050042706 Methods for the identification of inhibitors of porphobilinogen deaminase as antibiotics |
02/24/2005 | US20050042684 Binding phenol oxidizing enzyme-peptide complexes |
02/24/2005 | US20050042681 Methods and formulations for diagnosing, monitoring, staging and treating heart failure |
02/24/2005 | US20050042670 Peptides associated with carboxypeptidase active site for use in identification of modulators for treatment of cell proliferative disorders |
02/24/2005 | US20050042648 Vitro sorting method |
02/24/2005 | US20050042645 Expression vector comprising nucleotide sequences coding nitric oxide synthase for use in preparation of herbicides, antibiotics, nematicides, fungicides, insecticides and anticancer agents |
02/24/2005 | US20050042634 B. anthracis prevention and treatment: mutant B. anthracis lacking luxS activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production |
02/24/2005 | US20050042629 Nucleotide sequence coding heat resistant polymerase for use as processivity and replication tool in DNA amplification |
02/24/2005 | US20050042626 Novel human kinase proteins and polynucleotides encoding the same |
02/24/2005 | US20050042624 Tumor antigen |
02/24/2005 | US20050042607 Parkin protein as ubiquitin ligase |
02/24/2005 | US20050042328 Culture product; yeast extracts; for food, beverages |
02/24/2005 | US20050042305 Cutting particle sizes; solvent extraction; reduced ribonuclease activity activation |
02/24/2005 | US20050042231 Useful in vaccines, and monoclonal antibodies against said immunogenic surface proteins; hybridoma cell line that produes said antibodies; use in diagnostic kits for determining presence, onset, or decrease in Leptospiral infection |
02/24/2005 | US20050042222 Methods of diagnosing thyroid carcinoma |
02/24/2005 | US20050042213 Administering rhodanine derivative and O,O*-dihydroxybenzenebis(p-amidophenol) derivative; metabolic, neurodegenerative and autoimmune diseases; wound healing, antiinflammatory, and anticarcinogenic agents; atherosclerosis, restenosis, nephropathy |
02/24/2005 | DE10006462B4 Produktion nicht-kariogener Zucker in transgenen Pflanzen Non-cariogenic sugar production in transgenic plants |
02/24/2005 | CA2852159A1 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters |
02/24/2005 | CA2535255A1 Improved halohydrin dehalogenases and related polynucleotides |
02/24/2005 | CA2534897A1 Process of making flowable hemostatic compositions and devices containing such compositions |
02/24/2005 | CA2534895A1 Hemostatic compositions containing sterile thrombin |
02/24/2005 | CA2534629A1 Engineered proteases for affinity purification and processing of fusion proteins |
02/24/2005 | CA2533910A1 Methods and compositions for amplification of dna |
02/24/2005 | CA2533838A1 Improved ketoreductase polypeptides and related polynucleotides |
02/24/2005 | CA2532557A1 Methods and compositions for determination of glycated proteins |
02/24/2005 | CA2529658A1 Engineering single-gene-controlled staygreen potential into plants |
02/24/2005 | CA2529553A1 Ribonucleases and methods of making them recombinantly |
02/24/2005 | CA2526595A1 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters |
02/24/2005 | CA2525969A1 Intron fusion proteins, and methods of identifying and using same |
02/23/2005 | EP1508805A1 Stabilizing agent and blocking agent |
02/23/2005 | EP1508619A1 Novel promoter |
02/23/2005 | EP1508617A1 Method for stabilizing an alanine aminotransferase and the corresponding compositions |
02/23/2005 | EP1508616A1 Method for stabilizing and aspartate aminotransferase and the corresponding compositions |
02/23/2005 | EP1508573A1 Stabilizing agent for enzymes |
02/23/2005 | EP1508572A1 PROTEIN INDUCING CELL DEATH OF i HELICOBACTER PYLORI /i |
02/23/2005 | EP1507870A2 Enzymes having dehalogenase activity and methods of use thereof |
02/23/2005 | EP1507869A2 Improved receptor detection |
02/23/2005 | EP1507866A2 Carotene synthase gene and uses therefor |
02/23/2005 | EP1507864A1 A method for production of plants with suppressed photorespiration and improved co2 fixation |
02/23/2005 | EP1507858A1 Method for the purification of microbial protease |
02/23/2005 | EP1507857A1 Novel pectinases and uses thereof |
02/23/2005 | EP1507856A1 Regulation of human serine/threonine kinase |
02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
02/23/2005 | EP1507854A1 New improved acyltransferase |
02/23/2005 | EP1507853A1 Palliative treatment for gluten intolerance |
02/23/2005 | EP1507852A2 Nucleic acids and proteins with thioredoxin reductase activity |
02/23/2005 | EP1507804A1 Active carbohydrate containing protecting reagents for chemical modifications, their production and use |
02/23/2005 | EP1507802A1 Transformed fungi for production of recombinant proteins |
02/23/2005 | EP1507776A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
02/23/2005 | EP1507546A2 Methods of using 22417, a novel human aminoprotease family member |
02/23/2005 | CN1585824A Enzymatic process for the manufacture of L-ascorbic acid and D-erythorbic acid |
02/23/2005 | CN1584596A Reagent box for external blood group and blood serum experimental determination |
02/23/2005 | CN1584595A External blood group and blood serum experimental determining method |
02/23/2005 | CN1584034A Corn tyrosin protein phosphatase gene and its coding protein and use |
02/23/2005 | CN1584033A Taxaceae 3-hydroxy-3-methylpentadiacyl cozymase A synthetic zymoprotein coding sequence |
02/23/2005 | CN1584032A Protein coding sequence of protein kinase 3 activated by cell division protoplasm for brassia rape |
02/23/2005 | CN1584026A Production of oligomeric xylose and special immobilized xylanase therefor |
02/23/2005 | CN1584025A Method for extracting cydonic chimosin |
02/23/2005 | CN1584024A Nitrile hydratase and its coding gene and use |
02/23/2005 | CN1584023A Recombined aspergillus oryzae tannase and its expression and purification |
02/23/2005 | CN1190495C Method for producing heterologous polypeptides in trichothecene-deficient filamentous fungal nutant cells |
02/23/2005 | CN1190494C System for expressing hyperther mostable protein |
02/22/2005 | US6858776 Plants having modified reproductive capacity |
02/22/2005 | US6858775 Method for generating split, non-transferable genes that are able to express an active protein product |
02/22/2005 | US6858772 Transgenic mice containing magnesium-dependent protein phosphatase gene disruptions |
02/22/2005 | US6858721 Method for producing cytosine nucleoside compounds |
02/22/2005 | US6858718 Hydrogen production |
02/22/2005 | US6858717 Method for obtaining modified polysaccharides |
02/22/2005 | US6858716 Drosophila recombination-associated protein and methods for use |
02/22/2005 | US6858714 Cyclic GMP phosphodiesterase |
02/22/2005 | US6858428 Nutrient broth for use in the suppression of apoptosis |
02/22/2005 | US6858427 Sphingosine kinases |
02/22/2005 | US6858425 Human acid alpha glucosidase gene and bovine alpha-S1 casein gene sequences |
02/22/2005 | US6858422 Lipase genes |
02/22/2005 | US6858421 Antiinflammatory agents; cyclooxygenases; enzyme inhibitors |
02/22/2005 | US6858420 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
02/22/2005 | US6858419 Comprises phosphorylating protein for diagnosis, prognosis, drug screening, clinical monitoring and treatment of hypertension |
02/22/2005 | US6858418 Polypeptide for use in the treatment of cardiovascular and cell proliferation disorders |
02/22/2005 | US6858417 Dna fragment carrying toluene monooxygenase, gene, recombinant plasmid, transformed microorganism, method for degrading chlorinated aliphatic hydrocarbon compounds and aromatic compounds, and method for environmental remediation |
02/22/2005 | US6858416 Human desaturase gene and uses thereof |
02/22/2005 | US6858415 Comprises enzymatic polypeptide for treatment and diagnsis of muscular, aberrant glycolysis and/or immunological disorders |